2016
The health registration in Cuba of HeberFERON® is approved, a unique Cuban product of its kind, which combines recombinant human interferon alpha 2b and recombinant human gamma interferon, for the treatment of skin cancer.
On August 5, the company Industrial Biotecnológico CIGB – Mariel S.A., a biotechnology research and industrial complex, was established. It is a Mercantile Society with 100% Cuban capital. Its main function is to direct investments in the Mariel Special Development Zone, for the production and commercialization of biotechnological products, from its initial conception to its start-up.